Navigation Links
Marrow-derived stem cells deliver new cytokine to kill brain tumor cells, offer protection

Attaching a recently discovered cytokine to neural stem cells derived from bone marrow, researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute have developed a tool to track and kill malignant brain tumor cells and provide long-term protection against their return.

Results of an animal study are published in the March 1, 2006 issue of Cancer Research, and the researchers are now applying to regulatory agencies to translate their work into human clinical trials.

Gliomas are highly invasive tumors with poorly defined borders that intermingle with healthy brain tissue, making complete surgical removal nearly impossible. Furthermore, cells separate from the main tumor and migrate to form satellites that escape treatment and often lead to recurrence.

Researchers at the Maxine Dunitz Neurosurgical Institute documented several years ago that some neural stem cells ?"immature" cells that can differentiate into central nervous system cells ?have the ability to target and track glioma cells in the brain, even as they migrate. The researchers identified the mechanism that enables certain neural stem cells to develop this tracking ability and genetically engineered neural stem cells to transport several cytokines ?proteins that regulate immune responses ?to track down and destroy glioma cells.

In 2002, the scientists reported that they had produced central nervous system cells from stem cells derived from bone marrow. Because these stem cells originate in the bone marrow instead of the brain or fetal or embryonic tissue, there is an unlimited supply of cells that are free of ethical and tissue-rejection issues.

This study provides the first documentation that the marrow-derived stem cells possess the same tumor-tracking capability of other neural stem cells. It also includes the first report on the use of the cytokine interleukin-23 (IL-23) as a potential gene-delivered therapy against glioma.

"The pape
'"/>

Source:Cedars-Sinai Medical Center


Page: 1 2 3

Related biology news :

1. Wisconsin scientists grow critical nerve cells
2. Spleen may be source of versatile stem cells
3. Researchers discover way to make cells in the eye sensitive to light
4. Priming embryonic stem cells to fulfill their promise
5. Lack of enzyme turns fat cells into fat burners
6. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
7. Elusive HIV shape change revealed; Key clue to how virus infects cells
8. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
9. Enzyme allows B cells to resist death, leading to leukemia
10. Scientists rid stem cell culture of key animal cells
11. Genetically modified natural killer immune cells attack, kill leukemia cells

Post Your Comments:
(Date:11/24/2009)...arctica has long held secrets of the earth,s histo...here has been very little information on the envir... for millions of years. Now, a team of researchers...funded to the tune of $10 million dollars by the N...bottom of things literally. These scientists will...
(Date:11/24/2009)...vember 24, 2009) New research on bacterial commun... reveals predictable temporal patterns, suggesting...rkers for monitoring climate change in the polar r...ceedings of the National Academy of Sciences Earl... six rivers shifted synchronously over time, corre...
(Date:11/23/2009)...arch presents strong evidence that the "synergisti...raffic-related pollution and indoor endotoxin caus...ther exposure alone. , Environmental health sc...ege of Medicine have shown that children exposed t...d indoor endotoxin during early life are six times...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 1Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 2As Good As a Deli For the Price of Making It At Home 52824 1As Good As a Deli For the Price of Making It At Home 52824 2Molecule plays early role in nonsmoking lung cancer 52821 1Molecule plays early role in nonsmoking lung cancer 52821 2
...that interfere with the action of one particular e...roblems led scientists at Johns Hopkins to create ...w them to see multiple, real-time chemical reacti...ublished July 21 in the journal ACS Chemical Biolo...est chemicals on enzymes isolated from their norma...
...enetic material intact, scientists at Johns Hopkin... vital to managing a yeast cell,s energy. They dis...l of one of them led the cell to turn off 70 perce...ely unprepared for such a dramatic event," says Je...ology and genetics at Hopkins and author of the st...
...ads of Earthlings, arrays of single-cell creatures...le devices are riding on the International Space S...nd the University of New Mexico, NASA and US Air F...ons were directed by yeast and other single cells ... even in the vacuum and radiation of outer space -...
Other Biology News:Hopkins researchers develop new tool to watch real-time chemical activity in cells 2Hopkins researchers develop new tool to watch real-time chemical activity in cells 3Johns hopkins researchers find link between cell's energy use and genome health 2Johns hopkins researchers find link between cell's energy use and genome health 3Sandia work launched on space shuttle shows live cells influence growth of nanostructures 2Sandia work launched on space shuttle shows live cells influence growth of nanostructures 3Sandia work launched on space shuttle shows live cells influence growth of nanostructures 4Sandia work launched on space shuttle shows live cells influence growth of nanostructures 5
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Brazil Bioethanol M...//www.reportlinker.com/p0165503/Brazil-Bioethanol-...Brazil Bioethanol Market Analysis and Forecasts to...tailed analysis and forecasts of the global bioeth...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...
(Date:11/24/2009)...HANGHAI, Nov. 24 /PRNewswire-Asia/ -- NOD Pharmace...rk Office (PTO) has allowed the patent application...logy. , NOD technology is a highly effici...nto bio-adhesive nano-particles to enable oral del...s. NOD technology is a platform technology,that ca...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...dingBlocks is market,s first service for pre-purch..., Dec. 9 The Scientific business of Thomson Reute... source for online access to industry codes and st... BuildingBlocks utility, allowing engineers to pre...hers such as ASTM (American Society for Testing a...
...H SAN FRANCISCO, Calif., Dec. 9 Proteolix, Inc. t...g that the company,s lead,product, carfilzomib, ha...nses,in patients with relapsed and refractory mult...lass of specific proteasome inhibitors being devel... malignancies and solid tumors. , Sundar Jag...
...TO, Calif., Dec. 9 BioMarin Pharmaceutical,Inc. (...Merck Serono, a division,of Merck KGaA, Darmstadt,...n(R) (sapropterin dihydrochloride) for the treatme...ia (PKU) or BH4 deficient patients,from the Europe...are,approximately 35,000 patients diagnosed with h...
Other Biology Technology:Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers 2Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 2Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 3Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 4Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 5Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology 6Kuvan Receives Marketing Approval in the European Union 2Kuvan Receives Marketing Approval in the European Union 3Kuvan Receives Marketing Approval in the European Union 4
Mouse Anti-Human MYO7A Monoclonal Antibody, Unconjugated, Clone 1D3 from Abnova Corporation
..., Functionally-Validated, Ion Channel Cell Lines ...l role in nerve and muscle function and consequent... Drugs that modulate ion channels have been invest...ain, cardiac arrhythmia, hypertension, local anaes...
Mouse Anti-Human TTC3 Monoclonal Antibody, Unconjugated, Clone 2D10 from Abnova Corporation
Mouse Anti-Human SYT4 Polyclonal Antibody, Unconjugated from Abnova Corporation
Biology Products: